Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Federica Fascì-Spurio"'
Autor:
Tiziana M. Attardo, Elena Magnani, Carlotta Casati, Danilo Cavalieri, Pietro Crispino, Federica Fascì Spurio, Stefano De Carli, Daniela Tirotta, Paola Gnerre
Publikováno v:
Italian Journal of Medicine, Vol 11, Iss 4, Pp 345-359 (2017)
Celiac disease (CD) is a complex polygenic disorder, which involves genetic factors human leukocyte complex (HLA) and non-HLA genes, environmental factors, innate and adoptive immunity, and a robust chronic T-mediated autoimmune component. The main g
Externí odkaz:
https://doaj.org/article/290ecf0f289a498ca3aba96e8b19c448
Publikováno v:
Digestive and Liver Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd2091823d66a0725b0681952651e66
Autor:
Daniela Tirotta, Federica Fascì Spurio, Stefano De Carli, Tiziana Attardo, Carlotta Casati, Elena Magnani, Paola Gnerre, P. Crispino, Danilo Cavalieri
Publikováno v:
Italian Journal of Medicine, Vol 11, Iss 4, Pp 345-359 (2017)
Celiac disease (CD) is a complex polygenic disorder, which involves genetic factors human leukocyte complex (HLA) and non-HLA genes, environmental factors, innate and adoptive immunity, and a robust chronic T-mediated autoimmune component. The main g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae489942f5f9fb36f5bb841634ba77e
http://www.italjmed.org/index.php/ijm/article/view/821
http://www.italjmed.org/index.php/ijm/article/view/821
Publikováno v:
Digestive and Liver Disease. 49:1092-1097
Aim To evaluate how Italian gastroenterologists use corticosteroids in clinical practice for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC). Material and methods All members of the Italian Group for Inflammatory Bowel Disease (IG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690ec3bfab76c41dec996f9abc3e2d54
https://doi.org/10.1016/j.dld.2017.07.005
https://doi.org/10.1016/j.dld.2017.07.005
Autor:
Alessandro Caroli, Irene Franceschet, Federica Fascì-Spurio, Lisa Girardi, Roberto Cappuccio, Davide Checchin, Francesca Lamboglia, Andrea Forti, Claudio Scarparo
Publikováno v:
Journal of Hepatology. 73:S792
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f1f1bad14dfe3cc19887d764660825d
https://doi.org/10.1016/s0168-8278(20)32031-6
https://doi.org/10.1016/s0168-8278(20)32031-6
Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 8:949-962
At present, therapy of inflammatory bowel disease is still far from being fully satisfactory; old drugs like steroids, for instance, still represent a cornerstone in the treatment of active disease despite their associated important side effects and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6c9328c796ddd83b4274a32d699847
https://doi.org/10.1586/17474124.2014.924396
https://doi.org/10.1586/17474124.2014.924396
Autor:
Federica Fascì-Spurio, Vito Annese, Giovanna Margagnoni, Claudio Papi, Francesca Rogai, Alessia Settesoldi
Publikováno v:
Digestive and Liver Disease. 45:978-985
In recent years mucosal healing has emerged as an important therapeutic goal for patients with inflammatory bowel disease. Growing evidence suggests that achieving mucosal healing can improve patient outcomes and, potentially, alter the course of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f417045fabc2a91ed1fc437cf674898
https://doi.org/10.1016/j.dld.2013.07.006
https://doi.org/10.1016/j.dld.2013.07.006
Autor:
Chiara Viganò, Gianmichele Meucci, Simone Saibeni, Claudio Papi, Cristina Bezzio, Federica Fascì-Spurio
Publikováno v:
Expert review of gastroenterologyhepatology. 11(1)
Ulcerative colitis (uc) is a chronic condition and for the vast majority of patients, life-long treatment is required. low adherence to therapy is an emerging issue. since low adherence is associated with poor clinical outcomes and increased costs, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381d614d8458ef67d1f746248675700b
https://pubmed.ncbi.nlm.nih.gov/27805459
https://pubmed.ncbi.nlm.nih.gov/27805459
Publikováno v:
Scandinavian journal of gastroenterology. 51(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea4b85a840e7bc9bf6356287d098361
https://pubmed.ncbi.nlm.nih.gov/26806276
https://pubmed.ncbi.nlm.nih.gov/26806276
Publikováno v:
Reviews on Recent Clinical Trials. 7:307-313
Most patients with Crohn's disease will require surgery during the course of their disease. However, surgery is not curative and post-operative recurrence is quite inexorable. One year after resection up to 80% of patients have new lesions at the neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1b957549bf6305ecad547e60128c7b7
https://doi.org/10.2174/1574887111207040307
https://doi.org/10.2174/1574887111207040307